Overview
Egypt's medical device market is expanding rapidly, driven by healthcare infrastructure investment, a growing population, and increasing demand for advanced diagnostic and therapeutic technologies. Registering a medical device in Egypt requires understanding the EDA's device classification system, preparing comprehensive technical documentation, and meeting ongoing post-market obligations.
Device Classification in Egypt
The EDA classifies medical devices into four risk-based categories, broadly aligned with the Global Harmonization Task Force (GHTF) framework:
- Class I (Low Risk) — non-invasive devices such as bandages, examination gloves, and hospital furniture
- Class IIa (Low-Medium Risk) — devices such as diagnostic ultrasound equipment, surgical instruments, and hearing aids
- Class IIb (Medium-High Risk) — devices such as ventilators, infusion pumps, and orthopedic implants
- Class III (High Risk) — devices such as cardiac pacemakers, drug-eluting stents, and implantable defibrillators
The classification determines the level of regulatory scrutiny, documentation requirements, and review timeline.
Registration Requirements
Technical Documentation
The EDA requires a technical file that typically includes:
- Device description — intended use, indications, contraindications, and operating principles
- Design and manufacturing information — materials, components, and manufacturing process
- Risk analysis — ISO 14971 risk management file
- Verification and validation — biocompatibility testing (ISO 10993), electrical safety (IEC 60601 for electromedical devices), software validation (IEC 62304 if applicable)
- Clinical evidence — clinical evaluation report with literature review and/or clinical investigation data
- Labeling — Arabic and English labels, instructions for use, and packaging artwork
Quality Management System
Manufacturers must demonstrate an established quality management system. The EDA recognizes:
- ISO 13485 certification from an accredited notified body
- CE marking documentation (for EU-registered devices)
- FDA 510(k) clearance or PMA approval (for US-registered devices)
Having regulatory approval from a recognized reference authority can expedite the Egyptian review process.
Local Authorized Representative
International medical device manufacturers must appoint a Local Authorized Representative (LAR) in Egypt. The LAR is responsible for:
- Acting as the regulatory contact point with the EDA
- Maintaining the technical file in Egypt
- Coordinating post-market surveillance activities
- Handling vigilance reporting for adverse events and device incidents
- Communicating field safety corrective actions
The Registration Process
Step 1: Classification Confirmation
Submit device information to the EDA for official classification. This establishes the regulatory pathway and documentation depth required.
Step 2: Documentation Preparation
Compile the technical file according to EDA requirements for the assigned device class. Higher-risk classes require more extensive clinical evidence and testing documentation.
Step 3: Application Submission
Submit the registration application along with the technical file, manufacturing certificates, free sale certificates, and authorization letter for the LAR.
Step 4: EDA Review
The EDA reviews the submission for completeness and scientific adequacy. For Class IIb and III devices, the review may include:
- Detailed technical assessment of design and manufacturing
- Clinical evidence evaluation
- Risk-benefit analysis
- Possible requests for additional data or clarification
Step 5: Registration Certificate
Upon successful review, the EDA issues a medical device registration certificate. The device can then be imported and marketed in Egypt through authorized distributors.
Timeline Expectations
- Class I devices — 3 to 6 months
- Class IIa devices — 6 to 9 months
- Class IIb devices — 9 to 15 months
- Class III devices — 12 to 24 months
These timelines assume complete documentation. Regulatory queries can extend the process significantly.
Post-Market Obligations
After registration, manufacturers and their LARs must maintain:
- Vigilance reporting — mandatory reporting of serious incidents and field safety corrective actions
- Post-market surveillance — systematic monitoring of device performance in the Egyptian market
- Periodic reporting — regular safety and performance reports to the EDA
- Registration renewal — timely renewal before certificate expiry
- Variation management — submitting applications for any changes to the registered device
How Epidis Pharma Supports Device Registration
Epidis Pharma provides Local Authorized Representation and complete regulatory affairs services for medical device manufacturers entering Egypt. Our team handles classification assessment, technical file preparation, EDA submission management, and ongoing post-market surveillance — providing a single point of contact for your Egyptian device registration needs.
